Patients with recurrent biliary tract cancer have a better prognosis than those with unresectable disease: retrospective analysis of a multi-institutional experience with patients of advanced biliary tract cancer who received palliative chemotherapy-Reference-Cited by-同舟云学术

Patients with recurrent biliary tract cancer have a better prognosis than those with unresectable disease: retrospective analysis of a multi-institutional experience with patients of advanced biliary tract cancer who received palliative chemotherapy

Published:2013-06-20 Issue:2 Volume:21 Page:98-104
ISSN:1868-6974
Container-title:Journal of Hepato-Biliary-Pancreatic Sciences
language:en
Short-container-title:J Hepatobiliary Pancreat Sci

Author:

Ikezawa Kenji¹,Kanai Masashi²,Ajiki Tetsuo³,Tsukamoto Tadashi⁴,Toyokawa Hideyoshi⁵,Terajima Hiroaki⁶,Furuyama Hiroaki⁷,Nagano Hiroaki⁸,Ikai Iwao⁹,Kuroda Nobukazu¹⁰,Awane Masaaki¹¹,Ochiai Toshiya¹²,Takemura Shigekazu¹³,Miyamoto Atsushi¹⁴,Kume Makoto¹⁵,Ogawa Masao¹⁶,Takeda Yutaka¹⁷,Taira Kaoru¹⁸,Ioka Tatsuya¹⁹

Affiliation:

1. Department of Hepatobiliary and Pancreatic Oncology; Osaka Medical Center for Cancer and Cardiovascular Diseases; 1-3-3 Nakamichi Higashinari-ku Osaka Osaka 537-8511 Japan

2. Kyoto University Hospital; Outpatient Oncology Unit; Kyoto University; Kyoto Japan

3. Department of Surgery; Division of Hepato-Biliary-Pancreatic Surgery; Kobe University; Graduate School of Medicine; Kobe Japan

4. Hepato-Biliary-Pancreatic Surgery; Osaka City General Hospital; Osaka Japan

5. Department of Surgery; Kansai Medical University; Osaka Japan

6. Department of Gastroenterological Surgery and Oncology; Kitano Hospital; The Tazuke Kofukai Medical Research Institute; Osaka Japan

7. Department of Abdominal Surgery; Tenri Hospital; Nara Japan

8. Department of Surgery; Osaka University; Graduate School of Medicine; Osaka Japan

9. Department of Surgery; National Hospital Organization Kyoto Medical Center; Kyoto Japan

10. Department of Surgery; Hyogo College of Medicine; Hyogo Japan

11. Department of Surgery; Kansai Electric Power Hospital; Osaka Japan

12. Department of Surgery; Kyoto Prefectural University of Medicine; Kyoto Japan

13. Department of Hepatobiliary Pancreatic Surgery; Osaka City University Graduate School of Medicine; Osaka Japan

14. Department of Surgery; Osaka National Hospital; Osaka Japan

15. Department of Surgery; Asahi University Murakami Memorial Hospital; Gifu Japan

16. Department of Surgery; Bell Land General Hospital; Osaka Japan

17. Hepato-Biliary-Pancreatic Surgery; Department of Surgery; Kansai Rosai Hospital; Hyogo Japan

18. Department of Surgery; Otsu Red Cross Hospital; Otsu Shiga Japan

19. Department of Hepatobiliary and Pancreatic Oncology; Osaka Medical Center for Cancer and Cardiovascular Diseases; Osaka Japan

Publisher

Wiley

Subject

Hepatology,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jhbp.2/fullpdf

Reference15 articles.

1. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma;Jarnagin;Ann Surg,2001

2. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer;Valle;N Engl J Med,2010

3. Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials;Eckel;Br J Cancer,2007

4. Prognostic factors in gallbladder and biliary tract cancer;Gomez-Roel;Med Oncol,2007

5. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer;Furuse;Cancer Chemother Pharmacol,2009

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An age-group analysis on the efficacy of chemotherapy in older adult patients with metastatic biliary tract cancer: a Japanese cancer registry cohort study;BMC Gastroenterology;2023-08-01

2. Radiation therapy for recurrent extrahepatic bile duct cancer;PLOS ONE;2021-06-16

3. Success rate of microsatellite instability examination and complete response with pembrolizumab in biliary tract cancer;JGH Open;2021-05-21

4. Risk stratification and prognostic nomogram for post-recurrence overall survival in patients with recurrent extrahepatic cholangiocarcinoma;HPB;2017-05

5. A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002);Cancer Chemotherapy and Pharmacology;2014-12-05